Video Interview: Claus Zieler of Astellas and EFPIA
Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe
I recently had the pleasure of speaking with Claus Zieler, Chief Commercial Officer at Astellas and a member of the board of EFPIA. He spoke with me about his career, as well as improvements he’d like to see in the regulatory framework in Europe.
In Europe, new medicines are often very slow to come to market because of fragmentation. The region is also no longer seen as competitive when it comes to new clinical trials. “Companies are right to ask: why should I perform this research or development in Europe if Europe doesn't give me access to a database, or makes it very slow for me to start a trial?” Zieler explained.
We’ve published articles based on the conversation, but in the digital age many of you may prefer to watch a video. You can check out the video interview below.
Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.
